Walgreen (WAG) Tops Q2 Views Amid Light Flu Season; PSC Takes Off in Sign-Ups
Tweet Send to a Friend
Get Alerts WAG Hot Sheet
Price: $50.77 +0.73%
Revenue Growth %: 0.0%
Financial Fact:
Selling, general and administrative expenses: 4.5B
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: 0.0%
Financial Fact:
Selling, general and administrative expenses: 4.5B
Today's EPS Names:
ANF, DXLG, FL, More
Trade WAG Now!
Walgreen (NYSE: WAG) shares are looking healthy Tuesday morning following the company's second-quarter 2012 results which showed a beat on the top and bottom lines amid a tough cold/flu season.
Revenue for the retail pharma giant moved 0.8 percent from $18.50 billion in the same period last year to $18.65 billion. Comps were down 1.5 percent, surprising when Walgreen reported front-end comps rose 2.1 percent, traffic was up 0.7 percent in comparable stores, and basket size jumped 1.4 percent.
Net earnings fell 7.6 percent to $683 million, or 78 cents per diluted share.
The Street expected revs of $18.53 billion and EPS of 77 cents.
Flu shots totaled 5.5 million, versus 6.2 million in the same period last year.
Comparable-store prescription sales dipped 3.9 percent, while overall prescription sales dropped 1.7 percent.
Walgreen said it had 700,000 new Prescription Savings Club sign-ups in January alone, following the exit of its partnership with Express Scripts (Nasdaq: ESRX).
***And, yes, we inquired: there is no special handshake or secret decoder ring given to you after signing-up to be part of the PSC.
Shares are up 2 percent Tuesday.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Revenue for the retail pharma giant moved 0.8 percent from $18.50 billion in the same period last year to $18.65 billion. Comps were down 1.5 percent, surprising when Walgreen reported front-end comps rose 2.1 percent, traffic was up 0.7 percent in comparable stores, and basket size jumped 1.4 percent.
Net earnings fell 7.6 percent to $683 million, or 78 cents per diluted share.
The Street expected revs of $18.53 billion and EPS of 77 cents.
Flu shots totaled 5.5 million, versus 6.2 million in the same period last year.
Comparable-store prescription sales dipped 3.9 percent, while overall prescription sales dropped 1.7 percent.
Walgreen said it had 700,000 new Prescription Savings Club sign-ups in January alone, following the exit of its partnership with Express Scripts (Nasdaq: ESRX).
***And, yes, we inquired: there is no special handshake or secret decoder ring given to you after signing-up to be part of the PSC.
Shares are up 2 percent Tuesday.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
